ClinicalTrials.Veeva

Menu

Accuracy of Noninvasive Pulse Oximeter Sensor (MightySat RX)

Masimo logo

Masimo

Status

Completed

Conditions

Healthy

Treatments

Device: MightySat RX Pulse Oximeter Sensor

Study type

Interventional

Funder types

Industry

Identifiers

NCT03125135
TR27761-TP16850A

Details and patient eligibility

About

In this study, the level of oxygen within the blood will be reduced in a controlled manner by reducing the concentration of oxygen the study volunteer breathes. The accuracy of a noninvasive pulse oximeter sensor will be assessed by comparison to the oxygen saturation measurements from a laboratory blood gas analyzer.

Enrollment

16 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Competent non-smoking adults

Inclusion Criteria:

  • Subjects must understand and consent to be in the study.
  • American Society of Anesthesiology Class 1 (Healthy subjects without any systemic disease at all).

Exclusion Criteria:

  • Subjects who have any systemic disease at all.
  • Subjects who do not understand the study and the risks.
  • Smokers.
  • Subjects who are pregnant.
  • Subjects having either signs or history of peripheral ischemia.
  • Others deemed ineligible by the clinical staff.

Trial design

Primary purpose

Other

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

16 participants in 1 patient group

Test Subject
Experimental group
Description:
All subjects are enrolled into the test group and all subjects receive the MightySat RX Pulse Oximeter Sensor.
Treatment:
Device: MightySat RX Pulse Oximeter Sensor

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems